Selected research
Industry Research
Pet Whole Blood and Blood Components Industry Research Report 2026
Market perspective
The global Pet Whole Blood and Blood Components market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pet Whole Blood and Blood Components is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pet Whole Blood and Blood Components is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pet Whole Blood and Blood Components is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pet Whole Blood and Blood Components include Thermo Fisher Scientific, Moregate BioTech, Bovogen Biologicals (ANZCO Foods Healthcare), Pel-Freez, LLC, HemoStat Laboratories, CellSera Australia (Auckland BioSciences), Animal Technologies, Serana Europe and Lake Immunogenics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pet Whole Blood and Blood Components market in terms of revenue (US$ million) and, where applicable, sales volume (kL), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kL) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pet Whole Blood and Blood Components Market by Company
Thermo Fisher Scientific
Moregate BioTech
Bovogen Biologicals (ANZCO Foods Healthcare)
Pel-Freez, LLC
HemoStat Laboratories
CellSera Australia (Auckland BioSciences)
Animal Technologies
Serana Europe
Lake Immunogenics
MoreCare. Inc.
Nanjing BioChannel Biotechnology Co., Ltd
Pet Whole Blood and Blood Components Segment by Type
Canine
Feline
Bovine
Sheep
Others
Pet Whole Blood and Blood Components Segment by Application
Veterinary Hospital
Clinic
Other
Pet Whole Blood and Blood Components Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Whole Blood and Blood Components market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Whole Blood and Blood Components and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Whole Blood and Blood Components.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pet Whole Blood and Blood Components manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pet Whole Blood and Blood Components by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pet Whole Blood and Blood Components in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Canine
- Feline
- Bovine
- Sheep
- Others
Applications
- Veterinary Hospital
- Clinic
- Other
Companies covered
- Thermo Fisher Scientific
- Moregate BioTech
- Bovogen Biologicals (ANZCO Foods Healthcare)
- Pel-Freez, LLC
- HemoStat Laboratories
- CellSera Australia (Auckland BioSciences)
- Animal Technologies
- Serana Europe
- Lake Immunogenics
- MoreCare. Inc.
- Nanjing BioChannel Biotechnology Co., Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pet Whole Blood and Blood Components Market Size (2021-2032)
- 2.2.2 Global Pet Whole Blood and Blood Components Sales (2021-2032)
- 2.2.3 Global Pet Whole Blood and Blood Components Market Average Price (2021-2032)
- 2.3 Pet Whole Blood and Blood Components by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Canine
- 2.3.3 Feline
- 2.3.4 Bovine
- 2.3.5 Sheep
- 2.3.6 Others
- 2.4 Pet Whole Blood and Blood Components by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Veterinary Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pet Whole Blood and Blood Components Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pet Whole Blood and Blood Components Sales (kL) of Manufacturers (2021-2026)
- 3.3 Global Pet Whole Blood and Blood Components Revenue of Manufacturers (2021-2026)
- 3.4 Global Pet Whole Blood and Blood Components Average Price by Manufacturers (2021-2026)
- 3.5 Global Pet Whole Blood and Blood Components Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pet Whole Blood and Blood Components, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pet Whole Blood and Blood Components, Product Type & Application
- 3.8 Global Manufacturers of Pet Whole Blood and Blood Components, Established Date
- 3.9 Global Pet Whole Blood and Blood Components Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher Scientific
- 4.1.1 Thermo Fisher Scientific Company Information
- 4.1.2 Thermo Fisher Scientific Business Overview
- 4.1.3 Thermo Fisher Scientific Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Scientific Pet Whole Blood and Blood Components Product Portfolio
- 4.1.5 Thermo Fisher Scientific Recent Developments
- 4.2 Moregate BioTech
- 4.2.1 Moregate BioTech Company Information
- 4.2.2 Moregate BioTech Business Overview
- 4.2.3 Moregate BioTech Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Moregate BioTech Pet Whole Blood and Blood Components Product Portfolio
- 4.2.5 Moregate BioTech Recent Developments
- 4.3 Bovogen Biologicals (ANZCO Foods Healthcare)
- 4.3.1 Bovogen Biologicals (ANZCO Foods Healthcare) Company Information
- 4.3.2 Bovogen Biologicals (ANZCO Foods Healthcare) Business Overview
- 4.3.3 Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bovogen Biologicals (ANZCO Foods Healthcare) Pet Whole Blood and Blood Components Product Portfolio
- 4.3.5 Bovogen Biologicals (ANZCO Foods Healthcare) Recent Developments
- 4.4 Pel-Freez, LLC
- 4.4.1 Pel-Freez, LLC Company Information
- 4.4.2 Pel-Freez, LLC Business Overview
- 4.4.3 Pel-Freez, LLC Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pel-Freez, LLC Pet Whole Blood and Blood Components Product Portfolio
- 4.4.5 Pel-Freez, LLC Recent Developments
- 4.5 HemoStat Laboratories
- 4.5.1 HemoStat Laboratories Company Information
- 4.5.2 HemoStat Laboratories Business Overview
- 4.5.3 HemoStat Laboratories Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 HemoStat Laboratories Pet Whole Blood and Blood Components Product Portfolio
- 4.5.5 HemoStat Laboratories Recent Developments
- 4.6 CellSera Australia (Auckland BioSciences)
- 4.6.1 CellSera Australia (Auckland BioSciences) Company Information
- 4.6.2 CellSera Australia (Auckland BioSciences) Business Overview
- 4.6.3 CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 CellSera Australia (Auckland BioSciences) Pet Whole Blood and Blood Components Product Portfolio
- 4.6.5 CellSera Australia (Auckland BioSciences) Recent Developments
- 4.7 Animal Technologies
- 4.7.1 Animal Technologies Company Information
- 4.7.2 Animal Technologies Business Overview
- 4.7.3 Animal Technologies Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Animal Technologies Pet Whole Blood and Blood Components Product Portfolio
- 4.7.5 Animal Technologies Recent Developments
- 4.8 Serana Europe
- 4.8.1 Serana Europe Company Information
- 4.8.2 Serana Europe Business Overview
- 4.8.3 Serana Europe Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Serana Europe Pet Whole Blood and Blood Components Product Portfolio
- 4.8.5 Serana Europe Recent Developments
- 4.9 Lake Immunogenics
- 4.9.1 Lake Immunogenics Company Information
- 4.9.2 Lake Immunogenics Business Overview
- 4.9.3 Lake Immunogenics Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lake Immunogenics Pet Whole Blood and Blood Components Product Portfolio
- 4.9.5 Lake Immunogenics Recent Developments
- 4.10 MoreCare. Inc.
- 4.10.1 MoreCare. Inc. Company Information
- 4.10.2 MoreCare. Inc. Business Overview
- 4.10.3 MoreCare. Inc. Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 MoreCare. Inc. Pet Whole Blood and Blood Components Product Portfolio
- 4.10.5 MoreCare. Inc. Recent Developments
- 4.11 Nanjing BioChannel Biotechnology Co., Ltd
- 4.11.1 Nanjing BioChannel Biotechnology Co., Ltd Company Information
- 4.11.2 Nanjing BioChannel Biotechnology Co., Ltd Business Overview
- 4.11.3 Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Nanjing BioChannel Biotechnology Co., Ltd Pet Whole Blood and Blood Components Product Portfolio
- 4.11.5 Nanjing BioChannel Biotechnology Co., Ltd Recent Developments
5 Global Pet Whole Blood and Blood Components Market Scenario by Region
- 5.1 Global Pet Whole Blood and Blood Components Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pet Whole Blood and Blood Components Sales by Region: 2021-2032
- 5.2.1 Global Pet Whole Blood and Blood Components Sales by Region: 2021-2026
- 5.2.2 Global Pet Whole Blood and Blood Components Sales by Region: 2027-2032
- 5.3 Global Pet Whole Blood and Blood Components Revenue by Region: 2021-2032
- 5.3.1 Global Pet Whole Blood and Blood Components Revenue by Region: 2021-2026
- 5.3.2 Global Pet Whole Blood and Blood Components Revenue by Region: 2027-2032
- 5.4 North America Pet Whole Blood and Blood Components Market Facts & Figures by Country
- 5.4.1 North America Pet Whole Blood and Blood Components Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pet Whole Blood and Blood Components Sales by Country (2021-2032)
- 5.4.3 North America Pet Whole Blood and Blood Components Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pet Whole Blood and Blood Components Market Facts & Figures by Country
- 5.5.1 Europe Pet Whole Blood and Blood Components Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pet Whole Blood and Blood Components Sales by Country (2021-2032)
- 5.5.3 Europe Pet Whole Blood and Blood Components Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pet Whole Blood and Blood Components Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pet Whole Blood and Blood Components Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pet Whole Blood and Blood Components Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pet Whole Blood and Blood Components Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pet Whole Blood and Blood Components Market Facts & Figures by Country
- 5.7.1 South America Pet Whole Blood and Blood Components Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pet Whole Blood and Blood Components Sales by Country (2021-2032)
- 5.7.3 South America Pet Whole Blood and Blood Components Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Pet Whole Blood and Blood Components Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pet Whole Blood and Blood Components Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pet Whole Blood and Blood Components Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pet Whole Blood and Blood Components Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pet Whole Blood and Blood Components Sales by Type (2021-2032)
- 6.1.1 Global Pet Whole Blood and Blood Components Sales by Type (2021-2032) & (kL)
- 6.1.2 Global Pet Whole Blood and Blood Components Sales Market Share by Type (2021-2032)
- 6.2 Global Pet Whole Blood and Blood Components Revenue by Type (2021-2032)
- 6.2.1 Global Pet Whole Blood and Blood Components Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pet Whole Blood and Blood Components Revenue Market Share by Type (2021-2032)
- 6.3 Global Pet Whole Blood and Blood Components Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pet Whole Blood and Blood Components Sales by Application (2021-2032)
- 7.1.1 Global Pet Whole Blood and Blood Components Sales by Application (2021-2032) & (kL)
- 7.1.2 Global Pet Whole Blood and Blood Components Sales Market Share by Application (2021-2032)
- 7.2 Global Pet Whole Blood and Blood Components Revenue by Application (2021-2032)
- 7.2.1 Global Pet Whole Blood and Blood Components Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pet Whole Blood and Blood Components Revenue Market Share by Application (2021-2032)
- 7.3 Global Pet Whole Blood and Blood Components Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pet Whole Blood and Blood Components Value Chain Analysis
- 8.1.1 Pet Whole Blood and Blood Components Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pet Whole Blood and Blood Components Production Mode & Process
- 8.2 Pet Whole Blood and Blood Components Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pet Whole Blood and Blood Components Distributors
- 8.2.3 Pet Whole Blood and Blood Components Customers
9 Global Pet Whole Blood and Blood Components Analyzing Market Dynamics
- 9.1 Pet Whole Blood and Blood Components Industry Trends
- 9.2 Pet Whole Blood and Blood Components Industry Drivers
- 9.3 Pet Whole Blood and Blood Components Industry Opportunities and Challenges
- 9.4 Pet Whole Blood and Blood Components Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst